News | Aug 23, 2007

Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio

Clinical Data, Inc. (NASDAQ: CLDA) announced today that it has acquired privately held Epidauros Biotechnologie AG of Bernried, Germany, in a cash transaction valued at 8.75 million euros (or approximately $11.84 million)

By: Clinical Data / Epidauros

NEWTON, Mass. / Bernried, Germany – August 23, 2007 – Clinical Data, Inc. (NASDAQ: CLDA) announced today that it has acquired privately held Epidauros Biotechnologie AG of Bernried, Germany, in a cash transaction valued at 8.75 million euros (or approximately $11.84 million). Epidauros brings to Clinical Data an established portfolio of proprietary genetic biomarkers, expertise in genetic biomarker discovery, relationships with leading diagnostic companies, and a fast-growing pharmacogenomics services business.

[to read more see attached PDF file]

For More Information

File(s)
	37_20070823_CLDA-Epidauros-FINAL915am_01.pdf	Size: 27 K